Laboratorio Antidoping FMSI, Federazione Medico Sportiva Italiana, Rome, Italy.
REDs-Research and Expertise on Anti-Doping Sciences, Institute of Sport Science, University of Lausanne, Lausanne, Switzerland.
Drug Test Anal. 2022 Aug;14(8):1438-1450. doi: 10.1002/dta.3269. Epub 2022 Apr 25.
This paper aimed to assess a method to measure eight thyroid-related compounds in serum by liquid chromatography-mass spectrometry (LC-MS/MS), to verify the correlation with radioimmunoassay (RIA), to evaluate the possible cross-reactivity, and to observe differences between athletes declaring the consumption of sodium levothyroxine and nonathletes serum samples. Validation was carried out to assess carryover, working range and linearity, limit of detection and limit of quantification, precision, matrix influence, recovery, accuracy, and uncertainty. Comparison between RIA and LC-MS/MS results was done. The assay was applied to serum samples, and comparison with RIA was done for T3 and T4 levels supported by RIA Thyroid-stimulating hormone (TSH) measurements. Validation parameters showed satisfactory results. Correlation between RIA and LC-MS/MS for T3 and T4 showed good results, but a cross-reactivity between T3 and T3AA was observed. Although no significant differences were proved, preliminary comparison between athletes and nonathletes serum samples showed a shift towards high values of TSH and lower for T4 values in the athletes' group. Differences between thyronine and T4AA concentrations and ratios were observed. The trend of T4 values supported by TSH measures might indicate subclinical hypothyroidism in athletes. This represents one of the most controversial thyroid statuses as different criteria about its treatment are described, especially since one of the exogenous causes is inadequate levothyroxine therapy. Because the variation of thyroid hormones and TSH has been extensively studied in high-performance sports, it is worth considering the need to set an adequate reference interval to accurately assess the thyroid status in athletes.
本文旨在评估一种通过液相色谱-质谱联用(LC-MS/MS)测定血清中八种甲状腺相关化合物的方法,验证与放射免疫分析(RIA)的相关性,评估可能的交叉反应,并观察运动员和非运动员血清样本中促甲状腺激素(TSH)水平的差异。验证过程包括评估交叉污染、工作范围和线性、检测限和定量限、精密度、基质影响、回收率、准确性和不精密度。比较了 RIA 和 LC-MS/MS 的结果。应用该方法检测了血清样本,并与 RIA 同时检测了 T3 和 T4 水平,同时进行了 RIA TSH 测量。验证参数显示结果令人满意。RIA 和 LC-MS/MS 对 T3 和 T4 的相关性结果良好,但 T3 和 T3AA 之间存在交叉反应。尽管未证明存在显著差异,但运动员和非运动员血清样本的初步比较显示,运动员组 TSH 水平较高,而 T4 值较低。观察到甲状腺素和 T4AA 浓度和比值的差异。TSH 测量支持的 T4 值下降可能表明运动员存在亚临床甲状腺功能减退。这是最具争议的甲状腺状态之一,因为其治疗的标准不同,尤其是因为其中一个外源性原因是甲状腺素替代治疗不足。由于在高水平运动中已经广泛研究了甲状腺激素和 TSH 的变化,因此值得考虑需要设定适当的参考区间,以准确评估运动员的甲状腺状态。